Clinical Trial

A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to evaluate a multiple health behavior change intervention for weight loss and smoking cessation using medication (Naltrexone + Bupropion) and behavior therapy in adults seeking bariatric surgery. The intervention will be compared to a standard of care control group.
Protocol Amendment History 1 change
notable Sponsor changed: Yale University -> Medical University of South Carolina 2026-07-09
Trial Details
NCT Number NCT07398404
Lead Sponsor Medical University of South Carolina
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Obesity, Smoking Cessation, Bariatric Surgery Patients
Enrollment 64 participants
Start Date 2026-09-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2031-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-08